Back

Translational readthrough as a potential therapeutic for AIPL1-associated Leber Congenital Amaurosis in a patient-derived iPSC-retinal organoid model

Leung, A.; Sacristan-Reviriego, A.; Perdigao, P.; Sai, H.; Georgiou, M.; Kalitzeos, A.; Carr, A.-J. F.; Coffey, P. J.; Michaelides, M.; Bainbridge, J.; Cheetham, M. E.; van der Spuy, J.

2021-12-18 cell biology
10.1101/2021.12.17.473147 bioRxiv
Show abstract

Leber Congenital Amaurosis type 4 (LCA4), caused by AIPL1 mutations, is characterised by severe sight impairment in infancy and rapidly progressive degeneration of photoreceptor cells. We generated retinal organoids using induced pluripotent stem cells (iPSCs) from renal epithelial cells obtained from four children with AIPL1 nonsense mutations. iPSC-derived photoreceptors exhibited the molecular hallmarks of LCA4, including undetectable AIPL1 and rod cGMP phosphodiesterase (PDE6) compared to control or CRISPR corrected organoids. Moreover, increased levels of cGMP were detected. The translational readthrough inducing drug (TRID) PTC124 was investigated as a potential therapeutic. LCA4 retinal organoids exhibited rescue of AIPL1 and PDE6; however, the level of full-length, functional AIPL1 induced through PTC124 treatment was insufficient to reduce cGMP levels and fully rescue the LCA4 phenotype. LCA4 retinal organoids are a valuable platform for the in vitro investigation of the molecular mechanisms that drive photoreceptor loss and for the evaluation of novel therapeutics.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Clinical and Translational Medicine
○ 30 papers in training set
Top 0.1%
15.2%
2
Scientific Reports
○ 3102 papers in training set
Top 8%
9.4%
3
eLife
● 5422 papers in training set
Top 19%
4.4%
4
Cell Death & Disease
○ 126 papers in training set
Top 0.3%
3.7%
5
Frontiers in Cell and Developmental Biology
○ 218 papers in training set
Top 2%
3.2%
6
Cell Reports Medicine
○ 140 papers in training set
Top 2%
3.2%
7
Cellular and Molecular Life Sciences
○ 84 papers in training set
Top 0.1%
2.8%
8
Molecular Therapy
○ 71 papers in training set
Top 1.0%
2.4%
9
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
○ 25 papers in training set
Top 0.1%
2.4%
10
Frontiers in Medicine
○ 113 papers in training set
Top 2%
2.2%
11
iScience
○ 1063 papers in training set
Top 9%
2.1%
50% of probability mass above
12
Cells
○ 232 papers in training set
Top 1%
2.1%
13
Cell Proliferation
○ 12 papers in training set
Top 0.1%
1.9%
14
Investigative Ophthalmology & Visual Science
● 22 papers in training set
Top 0.2%
1.8%
15
Nature Communications
○ 4913 papers in training set
Top 49%
1.8%
16
Cell Discovery
○ 54 papers in training set
Top 3%
1.7%
17
Communications Biology
○ 886 papers in training set
Top 8%
1.7%
18
International Journal of Molecular Sciences
○ 453 papers in training set
Top 8%
1.5%
19
Annals of Translational Medicine
○ 17 papers in training set
Top 0.8%
1.4%
20
PLOS ONE
● 4510 papers in training set
Top 61%
1.1%
21
Advanced Science
○ 249 papers in training set
Top 15%
1.0%
22
Aging
○ 69 papers in training set
Top 2%
0.8%
23
Investigative Opthalmology & Visual Science
● 37 papers in training set
Top 0.6%
0.8%
24
Human Mutation
○ 29 papers in training set
Top 0.6%
0.8%
25
EBioMedicine
○ 39 papers in training set
Top 0.9%
0.8%
26
European Respiratory Journal
● 54 papers in training set
Top 2%
0.8%
27
Neurobiology of Disease
○ 134 papers in training set
Top 4%
0.8%
28
Molecular Therapy Nucleic Acids
○ 32 papers in training set
Top 0.7%
0.8%
29
FASEB BioAdvances
○ 15 papers in training set
Top 0.3%
0.8%
30
Frontiers in Molecular Biosciences
○ 100 papers in training set
Top 4%
0.8%